NBY AMEX
NovaBay Pharmaceuticals, Inc.
1W: +25.3%
1M: +27.0%
3M: -93.6%
YTD: -93.6%
1Y: -0.5%
3Y: -99.0%
5Y: -100.0%
$1.47
Last traded 2026-04-06 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
36 relationships34
As Filer
counterparties named
2
As Counterparty
mentioned by others
7
Rel. Types
2021-09-28
Earliest Filing
2026-01-20
Latest Filing
target: 10
acquirer: 8
investor: 5
partner: 4
customer: 3
licensee: 2
supplier: 2
Counterparties (Filed by NBY)
34 relationshipsCompanies named in NBY's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Virtu Americas LLC | — | partner | Sales agent for the ATM offering of NovaBay Pharmaceuticals, Inc. | 2026-01-20 | View |
| R01 Fund LP | — | investor | Purchased Series D and Series E Preferred Stock and Pre-Funded Warrants | 2025-10-20 | View |
| Framework Ventures IV L.P. | — | investor | Purchased Series D and Series E Preferred Stock and Pre-Funded Warrants | 2025-10-20 | View |
| NovaBay Pharmaceuticals, Inc. | NBIX | acquirer | Company entering settlement agreement to resolve warrant disputes and facilitate asset sale dissolution. | 2025-03-11 | View |
| Sabby Volatility Warrant Master Fund Ltd. | — | target | Warrant holder entering settlement agreement to resolve disputes and sell remaining warrants. | 2025-03-11 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | partner | Company retaining Lucid as financial advisor | 2025-03-07 | View |
| Lucid Capital Markets, LLC | LCID | partner | Financial advisor retained by NovaBay Pharmaceuticals, Inc. | 2025-03-07 | View |
| PRN Physician Recommended Nutriceuticals, LLC | — | acquirer | Acquired NovaBay's Avenova eyecare business for $11.5 million | 2025-01-23 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | target | Company selling eyecare business and seeking dissolution | 2025-01-23 | View |
| Phase One Health, LLC | — | acquirer | Buyer of trademarks in a Trademark Acquisition Agreement | 2025-01-10 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | target | Seller of trademarks in a Trademark Acquisition Agreement | 2025-01-10 | View |
| RoundTable Healthcare Investors V, L.P. | — | investor | Lender providing funding commitment to Buyer | 2024-11-06 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | target | Seller in the asset purchase agreement | 2024-11-06 | View |
| PRN Physician Recommended Nutriceuticals, LLC | — | acquirer | Buyer in the asset purchase agreement | 2024-11-06 | View |
| RoundTable Healthcare Partners V, L.P. | — | investor | Lender providing funding commitment to Buyer | 2024-11-06 | View |
| Acumen Health Holdings, LLC | — | investor | Lender providing funding commitment to Buyer | 2024-11-06 | View |
| PRN PHYSICIAN RECOMMENDED NUTRICEUTICALS, LLC | — | target | Buyer in asset purchase agreement | 2024-09-20 | View |
| NOVABAY PHARMACEUTICALS, INC. | NBY | acquirer | Seller in asset purchase agreement | 2024-09-20 | View |
| New Age Investments LLC | — | customer | Buyer of 100% of the membership units of DERMAdoctor, LLC in the Sale Transaction. | 2024-03-25 | View |
| DERMAdoctor, LLC | — | customer | Subsidiary whose membership units are being sold in the Sale Transaction and whose guarantee obligations are being relea | 2024-03-25 | View |
| New Age Investments LLC | — | acquirer | Buyer purchasing membership units of DERMAdoctor | 2024-03-14 | View |
| DERMAdoctor, LLC | — | target | Target company whose membership units are being sold | 2024-03-14 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | target | Seller owning 100% of DERMAdoctor membership units | 2024-03-14 | View |
| Novabay Pharmaceuticals, Inc. | NBY | licensee | Licensor granting exclusive license for Avenova marks | 2024-01-10 | View |
| Sonoma Pharmaceuticals, Inc. | SNOA | licensee | Licensee receiving exclusive license for Ocudox products | 2024-01-10 | View |
| NOVABAY PHARMACEUTICALS, INC. | NBY | customer | Tenant in an office lease amendment | 2022-01-28 | View |
| KBSIII TOWERS AT EMERYVILLE, LLC | — | supplier | Landlord in an office lease amendment | 2022-01-28 | View |
| KBS Capital Advisors, LLC | — | partner | Authorized agent for the Landlord | 2022-01-28 | View |
| LAZ Parking | — | supplier | Provider of parking services | 2022-01-28 | View |
| NovaBay Pharmaceuticals, Inc. | NBY | acquirer | Acquiring company in the transaction where DERMAdoctor becomes a wholly-owned subsidiary. | 2021-11-12 | View |
| NovaBay Pharmaceuticals, Inc. | NBIX | acquirer | Acquiring 100% of DERMAdoctor membership units | 2021-09-28 | View |
| DERMAdoctor, LLC | — | target | Target company being acquired by NovaBay | 2021-09-28 | View |
| Papillon Partners, Inc. | — | target | Seller of membership units in DERMAdoctor | 2021-09-28 | View |
| Midwest Growth Partners, L.L.L.P. | — | target | Seller of membership units in DERMAdoctor | 2021-09-28 | View |
Mentioned As Counterparty
2 mentionsOther companies that named NBY in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-04-06 | Earnings Release; Exhibits | View | |
| 2026-04-01 | Officer/Director Change; Bylaws Amendment; Exhibits | View | |
| 2026-03-23 | Earnings Release; Regulation FD; Other Events; Exhibits | View | |
| 2026-03-12 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2026-02-20 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-02-12 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-30 | Changes in Registrant's Certifying Accountant; Other Events | View | |
| 2026-01-28 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2026-01-20 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-01-16 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-10-22 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-21 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-20 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-10-09 | Departure/Election of Directors; Appointment of Officers; Other Events | View | |
| 2025-09-18 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-08-26 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-19 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-04-22 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-03-11 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-03-07 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR